| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO R H GBP DIS | RVI JAPÓN | 55,70% | 107,49% | 109,04% | · |
| BARINGS ASIA GROWTH FUND A GBP INC | RVI ASIA EX-JAPÓN | 55,69% | 45,72% | 6,56% | 140,70% |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO I H GBP DIS | RVI JAPÓN | 55,68% | 107,20% | 108,86% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 55,67% | 8,63% | -31,20% | · |
| SCHRODER ISF ASIAN OPPORTUNITIES C ACC SGD | RVI ASIA EX-JAPÓN | 55,67% | 41,75% | 18,70% | · |
| BGF EMERGING MARKETS SUSTAINABLE EQUITY X2 NZD | RVI EMERGENTES | 55,64% | 49,13% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO IO USD CAP | RVI EMERGENTES | 55,64% | 59,95% | 22,22% | 153,08% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO IO GBP CAP | RVI EMERGENTES | 55,62% | 59,19% | 22,27% | 152,93% |
| GVCGAESCO MULTINACIONAL, FI A | RVI GLOBAL | 55,62% | 66,61% | 72,03% | 172,38% |
| UBS (LUX) KEY SELECTION SICAV - ASIAN EQUITIES (USD) (EUR) Q-ACC | RVI ASIA EX-JAPÓN | 55,61% | 52,79% | 15,89% | · |
